Release date:  August 15, 2024
 
    Expiration date:  August 14, 2026
  
Estimated Time of Completion:  60 minutes
 
 
        
   Session Agenda
  - Implementing Systems for HCV Treatment  in the Community: Sarah Hoehnen, DO
- Philosophy of Care – How to  Approach Medications for OUD and HCV: Dana Vallangeon, MD
Description
Watch the OH-HEP  Training Program, a free, easily accessible training program available to  providers across the state. It will meet the needs of both primary care  providers interested in providing hepatitis C care and current Ohio Medicaid  and private payor requirements. OH-HEP is designed to build (educate and  empower) a mentorship platform that is accessible to primary care providers  caring for high-risk individuals in every part of Ohio, especially in rural,  low resource settings.
   
 
  
Learning Objectives
 
 
 
 
  - Define  how organizational awareness can impact HCV treatment and develop a business  case. 
- Identify  screening tools that can be utilized by the entire care team. 
- Define  how HCV is a public health crisis. 
- Identify  tools within electronic health records (EHR) to create efficiencies. 
- Identify  resources for writing HCV prescriptions. 
- Review  harm reduction vs abstinence only philosophies of care for substance use  disorder (SUD) care. 
- Examine specific harm reduction strategies in medications for opioid use disorder (MOUD) and HCV care. 
- Review  and understand the three FDA-approved medications for opioid use disorder  (OUD). 
 
  
 
 
  
Target Audience
 
 
 
   The OH-HEP training series is targeted to Ohio-based primary care, infectious disease, gastroenterology, hepatology providers, advanced practice providers (nurses, nurse practitioners, and physician assistants), and pharmacists involved in Hepatitis C treatment or wishing to establish a collaborative practice agreement at their own institution.
 
 
  
 
 
  
Accreditation
 
 
 
   Cleveland Clinic Center for Continuing  Education is jointly accredited by the Accreditation Council for Continuing Medical  Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and  the American Nurses Credentialing Center (ANCC), to provide continuing  education for the healthcare team. 
 
Physicians /  American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet  enduring activity for a maximum of 1.0 AMA PRA Category 1  Credits™. Physicians should claim  only the credit commensurate with the extent of their participation in the activity. 
Participants  claiming CME credit from this activity may submit the credit hours to the  American Osteopathic Association for Category 2 credit. 
Nurses /  American Nurses Credentialing Center (ANCC)
  Cleveland Clinic Center for Continuing Education designates this internet live  activity for a maximum of 1.0 ANCC contact hours. 
Physician  Assistants / American Academy of PAs (AAPA)
  Cleveland Clinic Center for Continuing Education has been authorized by the  American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for  activities planned in accordance with AAPA CME Criteria. This activity is  designated for 1.0 AAPA Category 1 CME  credits. PAs should only claim credit commensurate with the extent of their  participation. 
Pharmacists / Accreditation  Council of Pharmacy Education (ACPE)
  Cleveland Clinic Center for Continuing Education designates this  knowledge-based activity for a maximum of 1.0 hours. Credit will be provided to NABP CPE Monitor  within 60 days after the activity completion. 
Universal  Activity Number List:
  Pharmacist:  
  Pharmacy Tech: 
Certificate  of Participation
A  certificate of participation will be provided to other health care  professionals for requesting credits in accordance with their professional  boards and/or associations.
     
  
 
 
  
Activity Director and Faculty
 
 
 
      Activity Director
       Erika Harrington
  Clinical Pharmacist
  Cleveland Clinic
  Cleveland, OH
 Planning Committee 
Sarah  Hoehnen, DO
  Medical Director of Infectious Disease
  Signature Health, Inc.
Mentor, OH
Sara Sasser, PA-C
  Department of Hepatology
  Digestive Disease and Surgical Institute
  Cleveland Clinic
  Cleveland, OH
Dana  Vallangeon, MD
  Chief Medical Officer
  Ohio Association of Community Health Centers (OACHC)
  Columbus, OH
Cindy Willis, DNP
  Director of Nursing Education
  Cleveland Clinic
  Cleveland, OH
Independent Reviewers 
  
William Carey, MD  
  
Rebecca Freedman, PharmD 
Faculty
     Sarah  Hoehnen, DO
  Medical Director of  Infectious Disease
  Signature Health, Inc.
  Mentor, OH
Dana  Vallangeon, MD
  Chief Medical Officer
  Ohio Association of Community  Health Centers (OACHC)
  Columbus,  OH
 
  
 
 
  
CME Disclaimer
 
 
 
     The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
  
  
 
Disclosures
 In accordance with the Standards for Integrity and Independence issued by the Accreditation  Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for  Continuing Education requires resolution of all faculty conflicts of interest  to ensure CME activities are free of commercial bias.  
The  following faculty have indicated that they may have a relationship, which in  the context of their presentation(s), could be perceived as a potential  conflict of interest:
	
      
        | Erika    Harrington, BS |  | 
      
        | Gilead      Sciences, Inc. | Ownership      interest (stock, stock options in a publicly owned company)Teaching and Speaking
 | 
      
        | Abbvie      Pharmaceuticals | Ownership      interest (stock, stock options in a publicly owned company) | 
 
  The following faculty have indicated they have no relationship which, in the  context of their presentation(s), could be perceived as a potential conflict of  interest: 
 
  Sarah Hoehnen, DO
Sara Sasser, PA-C
Dana Vallangeon, MD
Cindy Willis, DNP
	
All reviewers have indicated that they have no relationship which in the context of their participation could be considered a conflict of interest.
Acknowledgment
      
      The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for partial support of this activity from:
      Gilead Sciences, Inc. 
	This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education.